Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Peptides ; 97: 70-78, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28987278

ABSTRACT

In this study, we hydrolyzed rice endosperm protein (REP) with pepsin and generated 20 fractions containing multifunctional cationic peptides with varying isoelectric point (pI) values using ampholyte-free isoelectric focusing (autofocusing). Subsequently, we determined antimicrobial activities of each fraction against the pathogens Prophyromonas gingivalis, Propionibacterium acnes, Streptocossus mutans, and Candida albicans. Fractions 18, 19, and 20 had pI values greater than 12 and exhibited antimicrobial activity against P. gingivalis, P. acnes, and C. albicans, but not against S. mutans. In further experiments, we purified and identified cationic peptides from fractions 18, 19, and 20 using reversed-phase high-performance liquid chromatography and matrix-assisted laser/desorption ionization-time-of-flight mass spectroscopy. We also chemically synthesized five identified peptides (RSVSKSR, RRVIEPR, ERFQPMFRRPG, RVRQNIDNPNRADTYNPRAG, and VVRRVIEPRGLL) with pI values greater than 10.5 and evaluated antimicrobial, lipopolysaccharide (LPS)-neutralizing, and angiogenic activities. Among these synthetic peptides, only VVRRVIEPRGLL exhibited antimicrobial activity against P. gingivalis, with an IC50 value of 87µM. However, all five cationic peptides exhibited LPS-neutralizing and angiogenic activities with little or no hemolytic activity against mammalian red blood cells at functional concentrations. These present data show dual or multiple functions of the five identified cationic peptides with little or no hemolytic activity. Therefore, fractions containing cationic peptides from REP hydrolysates have the potential to be used as dietary supplements and functional ingredients in food products.


Subject(s)
Angiogenic Proteins/chemistry , Anti-Infective Agents/chemistry , Antimicrobial Cationic Peptides/chemistry , Endosperm/chemistry , Oryza/chemistry , Plant Proteins/chemistry , Angiogenic Proteins/pharmacology , Animals , Anti-Infective Agents/pharmacology , Antifungal Agents/pharmacology , Antimicrobial Cationic Peptides/chemical synthesis , Bacteria/drug effects , Fungi/drug effects , Hemolysis/drug effects , Human Umbilical Vein Endothelial Cells , Humans , Hydrolysis , Inhibitory Concentration 50 , Lipopolysaccharides
2.
J Pept Sci ; 23(3): 252-260, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28185358

ABSTRACT

Previously, we showed that the antimicrobial cationic and amphipathic octadecapeptide AmyI-1-18 from rice α-amylase (AmyI-1) inhibited the endotoxic activity of lipopolysaccharide (LPS) from Escherichia coli. In addition, we demonstrated that several AmyI-1-18 analogs containing arginine or leucine substitutions, which were designed on the basis of the helical wheel projection of AmyI-1-18, exhibited higher antimicrobial activity against human pathogenic microorganisms than AmyI-1-18. In the present study, anti-inflammatory (anti-endotoxic) activities of five AmyI-1-18 analogs containing arginine or leucine substitutions were investigated. Two single arginine-substituted and two single leucine-substituted AmyI-1-18 analogs inhibited the production of LPS-induced nitric oxide in mouse macrophages (RAW264) more effectively than AmyI-1-18. These data indicate that enhanced cationic and hydrophobic properties of AmyI-1-18 are associated with improved anti-endotoxic activity. In subsequent chromogenic Limulus amebocyte lysate assays, 50% inhibitory concentrations (IC50 ) of the three AmyI-1-18 analogs (G12R, D15R, and E9L) were 0.11-0.13 µm, indicating higher anti-endotoxic activity than that of AmyI-1-18 (IC50, 0.22 µm), and specific LPS binding activity. In agreement, surface plasmon resonance analyses confirmed direct LPS binding of three AmyI-1-18 analogs. In addition, AmyI-1-18 analogs exhibited little or no cytotoxic activity against RAW264 cells, indicating that enhancements of anti-inflammatory and LPS-neutralizing activities following replacement of arginine or leucine did not result in significant increases in cytotoxicity. This study shows that the arginine-substituted and leucine-substituted AmyI-1-18 analogs with improved anti-endotoxic and antimicrobial activities have clinical potential as dual-function host defense agents. Copyright © 2017 European Peptide Society and John Wiley & Sons, Ltd.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antimicrobial Cationic Peptides/pharmacology , Arginine/chemistry , Leucine/chemistry , Lipopolysaccharides/antagonists & inhibitors , Plant Proteins/pharmacology , alpha-Amylases/pharmacology , Amino Acid Sequence , Amino Acid Substitution , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Antimicrobial Cationic Peptides/chemical synthesis , Antimicrobial Cationic Peptides/chemistry , Cell Line , Humans , Hydrophobic and Hydrophilic Interactions , Limulus Test , Lipopolysaccharides/chemistry , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Mice , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/biosynthesis , Oryza/chemistry , Plant Proteins/chemical synthesis , Plant Proteins/chemistry , Protein Binding , Structure-Activity Relationship , alpha-Amylases/chemical synthesis , alpha-Amylases/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...